APA

Giatromanolaki A., Koukourakis M. I., Sivridis E. & Fountzilas G. (20000601). c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival. : Anticancer research.

Chicago

Giatromanolaki A, Koukourakis M I, Sivridis E and Fountzilas G. 20000601. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival. : Anticancer research.

Harvard

Giatromanolaki A., Koukourakis M. I., Sivridis E. and Fountzilas G. (20000601). c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival. : Anticancer research.

MLA

Giatromanolaki A, Koukourakis M I, Sivridis E and Fountzilas G. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival. : Anticancer research. 20000601.